| Calcitriol | Approved Investigational Nutraceutical | CDH1 | 999 |
upregulated | [Calcitriol binds to and results in increased activity of VDR protein] which results in increased expression of CDH1 mRNA | 16q22.1 | |
| Calcitriol | Approved Investigational Nutraceutical | CDH1 | 999 |
upregulated | Calcitriol results in increased expression of CDH1 mRNA | 16q22.1 | |
| Calcitriol | Approved Investigational Nutraceutical | CDH3 | 1001 |
upregulated | Calcitriol results in increased expression of CDH3 mRNA | 16q22.1 | |
| Calcitriol | Approved Investigational Nutraceutical | CDK1 | 983 |
downregulated | Calcitriol results in decreased expression of CDK1 mRNA | 10q21.2 | |
| Calcitriol | Approved Investigational Nutraceutical | CDK2 | 1017 |
downregulated | Calcitriol results in decreased expression of CDK2 mRNA | 12q13.2 | |
| Calcitriol | Approved Investigational Nutraceutical | CDKN1A | 1026 |
upregulated | Calcitriol results in increased expression of CDKN1A mRNA | 6p21.2 | |
| Calcitriol | Approved Investigational Nutraceutical | CDKN1B | 1027 |
upregulated | Calcitriol results in increased expression of CDKN1B mRNA | 12p13.1 | |
| Calcitriol | Approved Investigational Nutraceutical | CDKN2B | 1030 |
upregulated | Calcitriol results in increased expression of CDKN2B mRNA | 9p21.3 | |
| Calcitriol | Approved Investigational Nutraceutical | CDKN2C | 1031 |
downregulated | Calcitriol results in decreased expression of CDKN2C mRNA | 1p32.3 | |
| Calcitriol | Approved Investigational Nutraceutical | CDKN2D | 1032 |
downregulated | Calcitriol results in decreased expression of CDKN2D mRNA | 19p13.2 | |
| Calcitriol | Approved Investigational Nutraceutical | CDKN2D | 1032 |
upregulated | Calcitriol results in increased expression of CDKN2D mRNA | 19p13.2 | |
| Calcitriol | Approved Investigational Nutraceutical | CDKN3 | 1033 |
downregulated | Calcitriol results in decreased expression of CDKN3 mRNA | 14q22.2 | |
| Calcitriol | Approved Investigational Nutraceutical | CDR2L | 30850 |
downregulated | Calcitriol results in decreased expression of CDR2L mRNA | 17q25.1 | |
| Calcitriol | Approved Investigational Nutraceutical | CDRT4 | 284040 |
upregulated | Calcitriol results in increased expression of CDRT4 mRNA | 17p12 | |
| Calcitriol | Approved Investigational Nutraceutical | CDS1 | 1040 |
upregulated | Calcitriol results in increased expression of CDS1 mRNA | 4q21.23 | |
| Calcitriol | Approved Investigational Nutraceutical | CDT1 | 81620 |
downregulated | Calcitriol results in decreased expression of CDT1 mRNA | 16q24.3 | |
| Calcitriol | Approved Investigational Nutraceutical | CDYL | 9425 |
upregulated | Calcitriol results in increased expression of CDYL mRNA | 6p25.1 | |
| Calcitriol | Approved Investigational Nutraceutical | CEACAM1 | 634 |
upregulated | Calcitriol results in increased expression of CEACAM1 mRNA | 19q13.2 | |
| Calcitriol | Approved Investigational Nutraceutical | CEACAM6 | 4680 |
upregulated | Calcitriol results in increased expression of CEACAM6 mRNA | 19q13.2 | |
| Calcitriol | Approved Investigational Nutraceutical | CEBPB | 1051 |
upregulated | Calcitriol results in increased expression of CEBPB mRNA | 20q13.13 | |
| Calcitriol | Approved Investigational Nutraceutical | CEBPD | 1052 |
upregulated | Calcitriol results in increased expression of CEBPD mRNA | 8q11.21 | |
| Calcitriol | Approved Investigational Nutraceutical | CECR6 | 27439 |
upregulated | Calcitriol results in increased expression of CECR6 mRNA | 22q11.1 | |
| Calcitriol | Approved Investigational Nutraceutical | CEL | 1056 |
downregulated | Calcitriol results in decreased expression of CEL mRNA | 9q34.13 | |
| Calcitriol | Approved Investigational Nutraceutical | CELSR1 | 9620 |
upregulated | Calcitriol results in increased expression of CELSR1 mRNA | 22q13.31 | |
| Calcitriol | Approved Investigational Nutraceutical | CELSR2 | 1952 |
upregulated | Calcitriol results in increased expression of CELSR2 mRNA | 1p13.3 | |